Topics

Pathways to Improving Functional Capacity in Older Patients With Chronic Kidney Disease and Cardiovascular Disease

2015-06-18 03:55:38 | BioPortfolio

Summary

The purpose of this research study is to study the effect of fish oil and bicarbonate (baking soda) on exercise. In this study fish oil, bicarbonate or both will be compared to placebo to see if study participants increase exercise capacity.

Description

Patients with chronic kidney disease (CKD) have a high morbidity and mortality from cardiovascular disease (CVD). Both conditions are common in older patients. Reduced exercise capacity predicts poorer outcomes in patients with CVD2 and CKD. Although exercise tolerance is impaired in CKD4 limited improvement in these patients is possible. A critical gap in knowledge is how to optimize exercise capacity in these patients to improve quality and possibly length of life.

In CKD, both structure and function of skeletal muscle are deranged. In addition, energy production by mitochondria which falls with age, and various diseases is also reduced in CKD. Recent studies from our group have reported that differences in mitochondrial function are associated with variances in physical ability, exercise capacity, and gait speed.

In preliminary data, patients entering our Cardiac Rehabilitation (CR) with Stage III CKD [glomerular filtration rate (GFR) of <60 ml/min/1.73 m2] had a decreased improvement in exercise capacity compared to those with a normal GFR (Δ1.7 vs 2.7 Metabolic Equivalents of Exercise or METs, p<0.05) despite the same degree of adherence. Exercise capacity after CR in patients with a reduced GFR was greater in n-3 polyunsaturated fatty acids (n-3 PUFA) users than in non-users [Δ MET 2.0 (1.4-2.5) vs 1.4 (1.1-1.7), p<0.05], suggesting that n-3 PUFA with exercise may be better than exercise alone. With beneficial clinical effects in CKD, n-3 PUFA are now being extensively investigated in the dialysis population. In other patient populations, including those with chronic obstructive pulmonary disease and dilated cardiomyopathy daily ingestion/use of n-3 polyunsaturated fatty acids (n-3 PUFA) or fish oil improves exercise capacity. This intervention is safe, simple and well-tolerated. Multiple lines of evidence suggest muscle and mitochondrial function improve with exercise and n-3 PUFA supplementation.Such treatment may improve mitochondrial bioenergetics by various mechanisms including up-regulation of mitochondrial biogenesis and genes involved in mitochondrial fatty acid oxidation, as well as increase in mitochondrial content, and function. Flow mediated vasodilation is impaired in CKD. It too may be improved by n-3 PUFA supplementation which could be an alternative mechanism for improved oxygen delivery to muscle in older patients with CAD and CKD as in the non-CKD population. A further possible benefit of n-3 PUFA is suppression of inflammation.

Current practice, however, is to enter patients with CAD and CKD into standard CR without prescription of n-3 PUFA.

Experimental and epidemiological studies indicate that acidemia and metabolic acidosis are associated with the development and progression of CKD and with increased mortality in these patients. Metabolic acidosis associated with CKD also contributes to skeletal muscle atrophy by activation of the ubiquitin-proteasome axis. Even slight correction of acidosis can improve the anabolic state of muscle by downregulation of the ubiquitin-proteasome system. Clinically, bicarbonate supplementation may improve muscle function. This intervention is also safe, simple and well-tolerated.

Given that muscular function is abnormal in CKD and that both n-3 PUFA and bicarbonate supplementation have been shown to improve muscular function and exercise capacity, it is our purpose in this investigation to study the effects of these substances on exercise capacity in patients with CAD and CKD.

The investigators propose a double-blind, placebo-controlled, randomized, 2x2 factorial design, pilot study of n-3 PUFA and/or oral bicarbonate use in older (age >60 years) CAD patients with concomitant CKD enrolling in a standard, 3-month CR program. The investigators will assess the effects of this intervention on exercise capacity, markers of inflammation and serum bicarbonate concentration. The investigator's goal is to obtain 8 evaluable patients per group. Exercise capacity will be measured by Oxygen (VO2) peak. Response to bicarbonate will be monitored by serum bicarbonate concentration. Since CKD may adversely affect muscle function both by acidosis and/or mitochondrial function, the investigator's propose that these may be mechanisms for the poorer exercise capacity in these patients. The investigator's overarching hypothesis is that exercise capacity response to CR in older patients with CKD may be modifiable by concomitant n-3 PUFA and/or bicarbonate use to suppress acidosis.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Conditions

Chronic Kidney Disease

Intervention

Fish Oil and Bicarbonate, Fish Oil and Bicarbonate Placebo, Fish Oil Placebo and Bicarbonate, Fish Oil Placebo and Bicarbonate Placebo

Status

Not yet recruiting

Source

Wake Forest School of Medicine

Results (where available)

View Results

Links

Published on BioPortfolio: 2015-06-18T03:55:38-0400

Clinical Trials [6129 Associated Clinical Trials listed on BioPortfolio]

Altering Bicarbonate Delivery During Hemodialysis to Affect Filtration of Indoxyl Sulfate

This is a non randomized crossover trial investigating whether changing the pattern of bicarbonate administration during hemodialysis will result in the more efficient filtration of highly...

Pilot Study of Sodium Bicarbonate in Generally Healthy People With Low Bicarbonate

The goal of this pilot study is to determine whether oral sodium bicarbonate can raise low serum bicarbonate concentration in people without chronic kidney disease (CKD). Participants will...

Use of Bicarbonate to Reduce the Incidence of Acute Renal Failure After Cardiac Surgery

The purpose of this study is to determine if the incidence of acute renal failure (ARF) in high risk patients who undergo coronary artery bypass grafting (CABG) is reduced by treating pati...

Extended Use of Sodium Bicarbonate in Patients With Cancer

This pilot phase I trial studies the safety of long-term use of sodium bicarbonate in patients with cancer. Sodium bicarbonate may neutralize tumor acidity and as a result may inhibit the ...

Comparative Effects of Fish Oil Supplementation and a Montelukast on EIB and Airway Inflammation in Asthma

Combining fish oil supplementation and Montelukast [a commonly used cyst LT1 receptor antagonist to treat exercise-induced bronchoconstriction (EIB)] will provide a greater antiinflammator...

PubMed Articles [2865 Associated PubMed Articles listed on BioPortfolio]

Enhanced hyperoxidation of peroxiredoxin 2 and peroxiredoxin 3 in the presence of bicarbonate/CO.

Hydrogen peroxide undergoes an equilibrium reaction with bicarbonate/CO to produce peroxymonocarbonate (HCO). Peroxymonocarbonate is more reactive with thiols than HO but it makes up only a small frac...

Buffered lidocaine 1%, epinephrine 1:100'000 with sodium bicarbonate (hydrogen carbonate) in a 3:1 ratio is less painful than a 9:1 ratio: A double-blind, randomized, placebo-controlled, crossover trial.

Neutralizing (buffering) lidocaine 1%, epinephrine 1:100,000 solutions (Lido/Epi) with sodium hydrogen carbonate (NaHCO) (bicarbonate) is widely used to reduce burning sensations during infiltration o...

Enteric-Coated Sodium Bicarbonate Attenuates Gastrointestinal Side-Effects.

Enteric-formulated capsules can mitigate gastrointestinal (GI) side effects following sodium bicarbonate (NaHCO3) ingestion; however, it remains unclear how encapsulation alters postingestion symptoms...

Increased intestinal carbonate precipitate abundance in the sea bream (Sparus aurata L.) in response to ocean acidification.

Marine fish contribute to the carbon cycle by producing mineralized intestinal precipitates generated as by-products of their osmoregulation. Here we aimed at characterizing the control of epithelial ...

Relationship of Serum Bicarbonate Levels with 1-Year Graft Function in Kidney Transplant Recipients in Switzerland.

Metabolic acidosis (MA) is common in kidney transplant recipients (KTRs). Several studies have shown that MA is involved in the progression of chronic kidney disease. However, it is unclear if there i...

Medical and Biotech [MESH] Definitions

Membrane proteins that allow the exchange of chloride ions for bicarbonate ions across the cellular membrane. The action of specific antiporters in this class serve important functions such as allowing the efficient exchange of bicarbonate across red blood cell membranes as they passage through capillaries and the reabsorption of bicarbonate ions by the kidney.

Bicarbonate transporters that move BICARBONATE IONS in exchange of CHLORIDE IONS or SODIUM IONS across membranes. They regulate acid-base HOMEOSTASIS, cell volume and intracellular pH. Members include CHLORIDE-BICARBONATE ANTIPORTERS (SLC4A1, 2, 3, and 9); SODIUM-COUPLED BICARBONATE TRANSPORTERS (SLC4A4 and 5, 7, 8 and 10); and a sodium borate cotransporter (SLC4A11 protein).

Fish of the genera ONCORHYNCHUS and Salmo in the family SALMONIDAE. They are anadromous game fish, frequenting the coastal waters of both the North Atlantic and Pacific. They are known for their gameness as a sport fish and for the quality of their flesh as a table fish. (Webster, 3d ed).

Food products manufactured from fish (e.g., FISH FLOUR, fish meal).

Proteins that cotransport sodium ions and bicarbonate ions across cellular membranes.

More From BioPortfolio on "Pathways to Improving Functional Capacity in Older Patients With Chronic Kidney Disease and Cardiovascular Disease"

Quick Search

Relevant Topic

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...


Searches Linking to this Trial